搜索
Ionis Pharmaceuticals Inc
IONS添加自选
45.280USD
+1.980+4.57%
收盘 10-09 16:00（美东）
7.52B总市值
亏损市盈率 TTM
Ionis Pharmaceuticals Inc (IONS) 营收表现
更新时间: 2020年12月31日业务
营业收入
占比
年报
年报
单季报
R&D revenue under collaborative agreements
SPINRAZA royalties
Product sales, net
Licensing and other Royalty revenue
FY2020
FY2019
R&D revenue under collaborative agreements
364.56M(49.99%)
770.15M(68.60%)
SPINRAZA royalties
286.58M(39.30%)
292.99M(26.10%)
Product sales, net
70.00M(9.60%)
42.25M(3.76%)
Licensing and other Royalty revenue
8.12M(1.11%)
17.20M(1.53%)